In a typical population of patients requiring implantable cardioverter-defibrillator (ICD) therapy without pacing, mostly for the primary prevention of sudden cardiac death, a subcutaneous ICD (S-ICD; ...
Abbott is teaming up with AtaCor Medical to develop a next-generation implantable cardioverter defibrillator (ICD) designed to treat dangerous cardiac arrhythmias without routing wires through the ...
Please provide your email address to receive an email when new articles are posted on . The FDA announced Medtronic has issued a recall of its implantable cardioverter defibrillators and cardiac ...
For older patients without an indication for pacing, the subcutaneous implantable cardioverter-defibrillator (S-ICD; Boston Scientific) provides results comparable to those seen with traditional ...
Please provide your email address to receive an email when new articles are posted on . An analysis of more 800 MRI examinations shows the scans do not induce clinically significant functional changes ...
Patients with an indication for an implantable cardiac defibrillator for primary prevention of sudden cardiac death and a sharply reduced left ventricular ejection fraction of 35% or less safely ...
Implantable cardioverter-defibrillator (ICD) generator replacement in Canadian patients with devices that were recalled was associated with an 8 percent rate of complications, according to a study in ...
A cardiologist and electrophysiologist familiar with Boston Scientific's novel products bets one has a very bright future ahead. Arundhati Parmar Boston Scientific had a great 2014, and many Wall ...
A study of heart failure patients who meet national guidelines for devices that stabilize and strengthen the heart's electrical system found that only half of eligible patients received the devices.
Years ago, during training, I remember a colleague dissing an early model of an implantable cardioverter-defibrillator (ICD) because it was primitive. All it did was shock ventricular tachycardia (VT) ...
Researchers at Tufts Medical Center report reassuring accuracy predicting which patients with a common genetic heart disease are at the most risk of sudden death and thus most need an implanted device ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results